{"id":"W4407148542","doi":"10.3389/fonc.2024.1511301","title":"Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Hazard ratio; Endometrial cancer; Adverse effect; Randomized controlled trial; Meta-analysis; Cochrane Library; Oncology; Lenvatinib; Subgroup analysis; Confidence interval; Cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01639926,0.003461898,0.0220315,0.007646774,0.000620918,0.003831187,0.002365222,0.002597271,0.003167917],"category_scores_gemma":[0.03498884,0.002114731,0.05065274,0.007364685,0.0007338728,0.001903251,0.001463111,0.001883976,0.0003133062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002617263,"about_ca_system_score_gemma":0.003334976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005742635,"about_ca_topic_score_gemma":0.01123944,"domain_scores_codex":[0.9883903,0.00600403,0.003161628,0.001058348,0.001109826,0.0002758601],"domain_scores_gemma":[0.9837535,0.01176271,0.002647201,0.00052107,0.001104439,0.000211085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001386165,0.00002436865,0.00167021,0.1981151,0.7912917,0.00007520359,0.00004321294,0.0004947435,0.0001504501,0.00008200132,0.0002448889,0.006422029],"study_design_scores_gemma":[0.0003970266,0.0001472749,0.001344818,0.01161531,0.9852604,0.00005445116,0.00002117078,0.0001544314,0.00006652803,0.0001224268,0.0008011587,0.00001494722],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004015119,0.9942305,0.0005794183,0.0002028561,0.0001502439,0.0002614656,0.0003246063,0.00002132224,0.0002145319],"genre_scores_gemma":[0.1817669,0.8110011,0.003200607,0.001041599,0.0003915558,0.001457078,0.00070243,0.00003837709,0.0004003572],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0220315,"threshold_uncertainty_score":0.08672857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03111834046985614,"score_gpt":0.3629342433540602,"score_spread":0.331815902884204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}